BGLAP and Alzheimer disease: Chang et al. (72) found that osteocalcin alleviated pathological conditions in Alzheimer’s disease (AD) model mice by reducing Aβ burden and enhancing the glycolysis of astrocytes and microglia, providing new insights for AD treatment.